2018 Pittsburgh International Lung Conference: Pulmonary Medicine: Basic Biology and Novel Therapies
October 4-5, 2018
University Club
123 University Place
Pittsburgh, PA 15260
Intent and Objectives
The Pittsburgh International Lung Conference is an educational conference held every other year to increase awareness of the medical and scientific advances being made in treating lung disease.
The title of this year’s Pitt Lung Conference is “Pulmonary Medicine: Basic Biology and Novel Therapies,” which will highlight the cutting-edge developments in seven core areas of Pulmonary Medicine: Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), Asthma, Interstitial Lung Disease (ILD), Lung Transplant, Interventional Pulmonary and Obstructive Sleep Apnea. The invited faculty will showcase the senior thought leaders in these topics and the rising stars who will shape Pulmonary Medicine in the near future.
In addition, we are pleased to welcome the chiefs of the pulmonary divisions from Brigham and Women’s Hospital, the University of Pennsylvania, and Johns Hopkins for a special session on the challenges facing trainees in Pulmonary and Critical Care Medicine. Our keynote speaker will be Judith Campisi, PhD, Professor of Biogerontology at the Buck Institute for Research on Aging.
The 2018 Pitt Lung Conference will not only serve as a forum for cutting-edge basic, translational, and clinical research in Pulmonary Medicine, but will also focus the conversation on how we as a community help protect and train tomorrow’s leaders in respiratory health.
Each session will end with a panel discussion with an opportunity for questions for further interaction among participants.
Who Should Attend
The target audience for this conference is practicing physicians, nurses, fellows-in-training, allied health personnel, basic and translational researchers, public health experts, industry scientists, and any other health care or academic professional with a major clinical or research interest in the role of the immune system as it pertains to Pulmonary Medicine.
Further, because the University of Pittsburgh and UPMC is an internationally recognized leader in pulmonary and critical care and research, the conference will also target biomedical researchers from around the United States, internationally, and within industry.
Faculty for this activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
Course Directors
Daniel J. Kass, MD
Associate Professor of Medicine
Director, Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease (ILD)
Division of Pulmonary, Allergy & Critical Care Medicine
University of Pittsburgh School of Medicine
John F. McDyer, MD
Associate Professor of Medicine
Director, Lung Transplantation Translational Research Program
Division of Pulmonary, Allergy & Critical Care Medicine
University of Pittsburgh School of Medicine
Continuing Education Credit
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals are awarded 1.3 continuing education units (CEU's) which are equal to 13.5 contact hours.
Related Material
Pittsburgh International Lung Conference Website
For more information, contact Theresa Dobransky at dobranskyta@upmc.edu.
